DNA Content and MHC Class II Antigen Expression in Malignant Melanoma: Clinical Course.

Journal of Clinical Pathology - United Kingdom
doi 10.1136/jcp.41.10.1078
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Antigen Processing for MHC Class II Presentation via Autophagy

Frontiers in Immunology
AllergyImmunology
2012English

Mice Lacking the MHC Class II Transactivator (CIITA) Show Tissue-Specific Impairment of MHC Class II Expression

Immunity
Infectious DiseasesAllergyImmunology
1996English

Altered Clinical Course of Malignant Melanoma in HIV-Positive Patients

Archives of Dermatology
2002English

The Role of the MHC Class II Transactivator in Class II Expression and Antigen Presentation by Astrocytes and in Susceptibility to Central Nervous System Autoimmune Disease

Journal of Immunology
AllergyImmunology
2002English

Induction and Isolation of Tumor Antigen-Specific CD4+ T Lymphocytes Using Sorting Signal Directed MHC Class-Ii Expression

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2013English

Uncovering the Role of Invariant Chain in Controlling MHC Class II Antigen Capture

Journal of Immunology
AllergyImmunology
2011English

MHC Class II Expression in Human Basophils: Induction and Lack of Functional Significance

PLoS ONE
Multidisciplinary
2013English

Histone Deacetylase Inhibitors Induce TAP, LMP, Tapasin Genes and MHC Class I Antigen Presentation by Melanoma Cells

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2007English

MHC Class II Tetramers and the Pursuit of Antigen-Specific T Cells: Define, Deviate, Delete

Clinical Immunology
AllergyImmunology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy